ADAPTIMMUNE LIMITED

• ⚠

  Material uncertainty over going concern

  Based on the above, the directors believe it remains appropriate to prepare the financial statements on a going concern basis. However, these circumstances indicate the existence of a material uncertainty related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern and, therefore, that the company may be unable to realise its assets and discharge its liabilities in the normal course of business.

• ◆

  5 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101 Reduced Disclosure Framework

Reporting scope

Standalone (parent only)

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“Based on the above, the directors believe it remains appropriate to prepare the financial statements on a going concern basis. However, these circumstances indicate the existence of a material uncertainty related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern and, therefore, that the company may be unable to realise its assets and discharge its liabilities in the normal course of business.”

Group structure

1. ADAPTIMMUNE LIMITED · parent
   1. Adaptimmune LLC 1% · United States of America · Biotechnology Research & Development
   2. Adaptimmune B.V. 1% · The Netherlands · Administrative

Significant events

• “During the fourth quarter of 2024 we announced that we were ceasing further investment in all non-core programmes. We are undertaking a reduction in headcount of approximately 29% and a reduction of total operating expenses of approximately 25% (as compared to 2024 operating expenses).”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

15

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

5

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +178.9%

  £49,448,000 → £137,920,000

• Cash

  -57.7%

  £32,344,000 → £13,671,000

• Net assets

  -7.4%

  -£615,379,000 → -£660,680,000

• Employees

  +1.3%

  233 → 236

• Operating profit

  +49%

  -£88,247,000 → -£45,010,000

• Profit before tax

  +11%

  -£62,206,000 → -£55,350,000

• Wages

  +7.4%

  £18,151,000 → £19,490,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers